GB202212092D0 - Gene therapy - Google Patents
Gene therapyInfo
- Publication number
- GB202212092D0 GB202212092D0 GBGB2212092.7A GB202212092A GB202212092D0 GB 202212092 D0 GB202212092 D0 GB 202212092D0 GB 202212092 A GB202212092 A GB 202212092A GB 202212092 D0 GB202212092 D0 GB 202212092D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- gene therapy
- therapy
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000001415 gene therapy Methods 0.000 title 1
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2212092.7A GB202212092D0 (en) | 2022-08-19 | 2022-08-19 | Gene therapy |
PCT/GB2023/052174 WO2024038287A1 (en) | 2022-08-19 | 2023-08-18 | Gene therapy for the treatment of argininosuccinate lyase deficiency |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2212092.7A GB202212092D0 (en) | 2022-08-19 | 2022-08-19 | Gene therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202212092D0 true GB202212092D0 (en) | 2022-10-05 |
Family
ID=83902259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2212092.7A Ceased GB202212092D0 (en) | 2022-08-19 | 2022-08-19 | Gene therapy |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202212092D0 (en) |
-
2022
- 2022-08-19 GB GBGB2212092.7A patent/GB202212092D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202114972D0 (en) | Gene therapy | |
IL309742A (en) | Optimized expression cassettes for gene therapy | |
GB202003618D0 (en) | Gene Therapy | |
GB201905301D0 (en) | Gene therapy | |
IL311499A (en) | Frataxin gene therapy | |
GB202003109D0 (en) | Gene therapy | |
GB202002202D0 (en) | Gene therapy | |
IL306119A (en) | Gene therapy for treating beta-hemoglobinopathies | |
GB202316264D0 (en) | Gene therapy | |
GB202315668D0 (en) | Gene therapy | |
GB202214445D0 (en) | Gene therapy | |
GB202212092D0 (en) | Gene therapy | |
GB202206346D0 (en) | Gene therapy | |
GB202108303D0 (en) | Therapy | |
GB202103164D0 (en) | Therapy | |
IL310017A (en) | Retgc gene therapy | |
IL310018A (en) | Kcnv2 gene therapy | |
GB202114973D0 (en) | Gene therapy | |
GB202010894D0 (en) | Gene therapy | |
SG11202110844UA (en) | Mixed-cell gene therapy | |
GB202003536D0 (en) | Gene therapy | |
GB202003120D0 (en) | Gene therapy | |
GB202001930D0 (en) | Gene therapy | |
GB202215198D0 (en) | Gene therapy treatment | |
GB202005321D0 (en) | Gene therapy treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |